• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Kim Westrich Discusses ACOs and Pharmacy Management

Video

Kimberly Westrich, director for health services research for the National Pharmaceutical Council (NPC), says that the NPC determined many accountable care organizations (ACOs) are not yet prepared to maximize the value of pharmaceuticals in patient care.

Kimberly Westrich, director for health services research for the National Pharmaceutical Council (NPC), says that the NPC determined many accountable care organizations (ACOs) are not yet prepared to maximize the value of pharmaceuticals in patient care. This lack of readiness is partly due to the fact that ACOs continue to struggle with quality measures for a broad diversity of conditions and a general inability to measure cost offsets, among other reasons.

ACO participants also have a variety of perspectives on medications as an essential part of condition management, but Ms Westrich says there are opportunities.

“When you look beneath the surface, you realize there is a lot of opportunity for medications to help lower costs in situations where perhaps they reduce readmissions to the hospital, or to achieve the important quality benchmarks CMS and others are looking for,” says Ms Westrich. “So an ACO that would thoughtfully use pharmaceuticals to maximize patient care can meet both their cost and quality benchmarks, and that’s the best way to be using them.”

Related Videos
Coral Omene, MD, PhD, sitting for a vieo interview
Dr Ola Landgren
David Awad, PharmD, BCOP
Gordon Crofoot, MD, PA
Jaime Almandoz, MD, MBA
Screenshot of Coral Omene, MD, PhD
Dr Brian Slomovitz
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
ASCO 2025
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.